No. 21-1-2, March 2018

Index

• Broadening the conversation on the TRIPS agreement: Access to medicines includes addressing access to medical devices
• Combating biopiracy in Australia: Will a disclosure requirement in the Patents Act 1990 be more effective than the current regulations?
• Impact of patent policy changes on R&D expenditure by industries in India
• Issue Information
• Japan's emerging role in the global pharmaceutical intellectual property regime: A tale of two trade agreements
• Open models for patents: Giving patents a new lease on life?
• WTO “Paragraph 6” system for affordable access to medicines: Relief or regulatory ritualism?